repligen - Robuta Search

https://www.fool.com/investing/2020/05/05/will-clinical-trial-delays-derail-repligens-growth.aspx Will Clinical Trial Delays Derail Repligen's Growth? | The Motley Fool May 5, 2020 - The bioprocess leader relies on clinical trials for a significant portion of revenue. How disruptive will the coronavirus be? clinical trial the motley delays https://www.biospace.com/repligen-appoints-maggie-a-pax-to-board-of-directors Repligen Appoints Maggie A. Pax to Board of Directors - BioSpace Mar 20, 2024 - Repligen Corporation announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax. board of directors repligen maggie pax biospace https://www.propertymentorgroup.com/trending-stocks-gtx-inc-nasdaqgtxi-repligen-corporation-nasdaqrgen-nvidia-corporation-nasdaqnvda-cleantech-solutions-international-nasdaqclnt-biostar-pharmaceuticals-nasdaqbspm/1286709/ Trending Stocks: GTX Inc. (NASDAQ:GTXI), Repligen Corporation (NASDAQ:RGEN), NVIDIA Corporation... On Friday shares of GTX Inc. (NASDAQ:GTXI) closed at $1.06. On May 08, GTx, Inc. (NASDAQ:GTXI) reported financial results for the first quarter ended March 31,... trending stocks gtx inc nasdaq repligen https://www.medicaldevice-network.com/news/newsdeals-this-week-repligen-cobe-capital-chembio-diagnostics-5855535/ Deals this week: Repligen, CoBe Capital, Chembio Diagnostics - Medical Device Network Jun 29, 2017 - US-based bioprocessing company Repligen Corp has announced a public offering of 2,807,017 shares priced at $42.75 each, to raise $120m. deals this week medical device repligen cobe https://djiboutihealthjournal.com/article/835785778-repligen-announces-strategic-partnership-with-novasign-to-further-advance-bioprocessing-digitalization Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing... strategic partnership further advance repligen announces bioprocessing https://www.benzinga.com/analyst-ratings/23/09/34285398/what-6-analyst-ratings-have-to-say-about-repligen What 6 Analyst Ratings Have To Say About Repligen - Repligen (NASDAQ:RGEN) - Benzinga have to say analyst ratings https://alternativemedicinetimes.com/article/911073910-repligen-corporation-to-present-at-bank-of-america-securities-2026-global-healthcare-conference Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference |... bank of america https://cyprushealthcarepress.com/article/835785778-repligen-announces-strategic-partnership-with-novasign-to-further-advance-bioprocessing-digitalization Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing... strategic partnership further advance repligen announces bioprocessing https://theorg.com/org/repligen Repligen | The Org Repligen is a bioprocessing-focused life sciences company repligen https://dailyhealthcarestlucia.com/article/911073910-repligen-corporation-to-present-at-bank-of-america-securities-2026-global-healthcare-conference Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference |... bank of america https://kuwaitbusinessjournal.com/article/911073910-repligen-corporation-to-present-at-bank-of-america-securities-2026-global-healthcare-conference Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference |... bank of america https://newmexicobusinesstoday.com/article/911073910-repligen-corporation-to-present-at-bank-of-america-securities-2026-global-healthcare-conference Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference |... bank of america https://wellnesswiremoldova.com/article/911073910-repligen-corporation-to-present-at-bank-of-america-securities-2026-global-healthcare-conference Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference |... bank of america